Wang Y - Search Results

1

Tumor Targeting of ²¹¹At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis.

Takashima H, Ohnuki K, Manabe S, Koga Y, Tsumura R, Anzai T, Wang Y, Yin X, Sato N, Shigekawa Y, Nambu A, Usuda S, Haba H, Fujii H, Yasunaga M. Takashima H, et al. Among authors: wang y. Mol Pharm. 2023 Feb 6;20(2):1156-1167. doi: 10.1021/acs.molpharmaceut.2c00869. Epub 2022 Dec 27. Mol Pharm. 2023. PMID: 36573995 Free PMC article.

2

Radioimmunotherapy with an ²¹¹ At-labeled anti-tissue factor antibody protected by sodium ascorbate.

Takashima H, Koga Y, Manabe S, Ohnuki K, Tsumura R, Anzai T, Iwata N, Wang Y, Yokokita T, Komori Y, Mori D, Usuda S, Haba H, Fujii H, Matsumura Y, Yasunaga M. Takashima H, et al. Among authors: wang y. Cancer Sci. 2021 May;112(5):1975-1986. doi: 10.1111/cas.14857. Epub 2021 Mar 30. Cancer Sci. 2021. PMID: 33606344 Free PMC article.

3

Stabilization of an ²¹¹At-Labeled Antibody with Sodium Ascorbate.

Manabe S, Takashima H, Ohnuki K, Koga Y, Tsumura R, Iwata N, Wang Y, Yokokita T, Komori Y, Usuda S, Mori D, Haba H, Fujii H, Yasunaga M, Matsumura Y. Manabe S, et al. Among authors: wang y. ACS Omega. 2021 May 31;6(23):14887-14895. doi: 10.1021/acsomega.1c00684. eCollection 2021 Jun 15. ACS Omega. 2021. PMID: 34151070 Free PMC article.

4

Comparison of the Therapeutic Effects of [²¹¹At]NaAt and [¹³¹I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model.

Watabe T, Liu Y, Kaneda-Nakashima K, Sato T, Shirakami Y, Ooe K, Toyoshima A, Shimosegawa E, Wang Y, Haba H, Nakano T, Shinohara A, Hatazawa J. Watabe T, et al. Among authors: wang y. Int J Mol Sci. 2022 Aug 21;23(16):9434. doi: 10.3390/ijms23169434. Int J Mol Sci. 2022. PMID: 36012698 Free PMC article.

5

Targeted α-therapy using astatine (²¹¹At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound.

Watabe T, Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Ooe K, Wang Y, Haba H, Toyoshima A, Cardinale J, Giesel FL, Tomiyama N, Fukase K. Watabe T, et al. Among authors: wang y. Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):849-858. doi: 10.1007/s00259-022-06016-z. Epub 2022 Nov 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 36344651 Free PMC article.

6

Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter.

Kaneda-Nakashima K, Shirakami Y, Watabe T, Ooe K, Yoshimura T, Toyoshima A, Wang Y, Haba H, Fukase K. Kaneda-Nakashima K, et al. Among authors: wang y. Int J Mol Sci. 2022 Dec 7;23(24):15509. doi: 10.3390/ijms232415509. Int J Mol Sci. 2022. PMID: 36555151 Free PMC article.

7

Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection.

Huang X, Kaneda-Nakashima K, Kadonaga Y, Kabayama K, Shimoyama A, Ooe K, Kato H, Toyoshima A, Shinohara A, Haba H, Wang Y, Fukase K. Huang X, et al. Among authors: wang y. Pharmaceutics. 2022 Dec 2;14(12):2705. doi: 10.3390/pharmaceutics14122705. Pharmaceutics. 2022. PMID: 36559199 Free PMC article.

8

Therapeutic efficacy of ²¹¹At-radiolabeled 2,6-diisopropylphenyl azide in mouse models of human lung cancer.

Ode Y, Pradipta AR, Ahmadi P, Ishiwata A, Nakamura A, Egawa Y, Kusakari Y, Muguruma K, Wang Y, Yin X, Sato N, Haba H, Tanaka K. Ode Y, et al. Among authors: wang y. Chem Sci. 2023 Jun 27;14(30):8054-8060. doi: 10.1039/d3sc02513f. eCollection 2023 Aug 2. Chem Sci. 2023. PMID: 37538829 Free PMC article.

9

Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with ⁸⁹Zr or ²¹¹At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma.

Watabe T, Kabayama K, Naka S, Yamamoto R, Kaneda K, Serada S, Ooe K, Toyoshima A, Wang Y, Haba H, Kurimoto K, Kobayashi T, Shimosegawa E, Tomiyama N, Fukase K, Naka T. Watabe T, et al. Among authors: wang y. J Nucl Med. 2023 Dec 1;64(12):1949-1955. doi: 10.2967/jnumed.123.266313. J Nucl Med. 2023. PMID: 37827841 Free PMC article.

10

Production of [²¹¹At]NaAt solution under GMP compliance for investigator-initiated clinical trial.

Naka S, Ooe K, Shirakami Y, Kurimoto K, Sakai T, Takahashi K, Toyoshima A, Wang Y, Haba H, Kato H, Tomiyama N, Watabe T. Naka S, et al. Among authors: wang y. EJNMMI Radiopharm Chem. 2024 Apr 15;9(1):29. doi: 10.1186/s41181-024-00257-z. EJNMMI Radiopharm Chem. 2024. PMID: 38619655 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296,464 results

Search Page

Filters